Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Nakamura, Minoru, Kondo, Hisayoshi, Mori, Tsuyoshi, Komori, Atsumasa, Matsuyama, Mutsumi, Ito, Masahiro, Takii, Yasushi, Koyabu, Makiko +30 more·2007·Hepatology
DOI 10.1002/hep.21472

Cited by (102)

Items 101–102 of 102

  1. Role of autoantibodies in the clinical management of primary biliary cholangitis
    Rigopoulou, Eirini I, Bogdanos, Dimitrios P · 2023 · World Journal of Gastroenterology
  2. Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis
    Huang, Chunyang, Han, Weijia, Wang, Chuanmin, Liu, Yanmin, Chen, Yue, Duan, Zhongping · 2019 · Disease Markers